Innovation & intellectual property · 20/05/2025

EPO Meets with Novo Nordisk to Discuss Quality and Health-Related Activities

The European Patent Office (EPO) recently met with Novo Nordisk to discuss quality and health-related activities, including the Unitary Patent and the EPO Observatory's health-related initiatives.